Mark White is a seasoned professional with extensive experience in business operations, pricing, and market access within the pharmaceutical industry. Currently serving as Senior Director of Business Operations at Emergent BioSolutions since November 2019, Mark oversees critical functions such as pricing, contracting, distribution, and 3PL management. Mark previously held roles including Director of Pricing and Contracting, where a successful strategy was developed for the NARCAN RX to OTC switch, and Senior Consultant at Health Strategies Insights, delivering impactful research and insights for pharmaceutical clients. Mark's background also includes key positions at Kendall Life Sciences LLC, Duchesnay USA, Connolly Healthcare, and AstraZeneca, where expertise in government programs, market access strategies, and rebate negotiations was demonstrated. Mark holds an MBA in Finance from Villanova University and a BS in Finance from the University of Scranton.
This person is not in any teams
This person is not in any offices